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Apparent Correlation Between Structure
and Carcinogenicity of Phenylenediamines
and Related Compounds
by Harry A. Milman* and Cheryl Peterson*
The carcinogenicity of23 phenylenediamines andrelated compounds was reviewed. An extensive analysis
of the methods used indicated that the bioassays were conducted well. The data suggest that the
carcinogenicity of4-substituted 1,3-phenylenediamines is reduced substantially or eliminated completely
by oxidation of one or both amine groups or by N-substitution. Oxidation of a methyl substituent on
nitroaniline to a carboxyl group eliminated all carcinogenic activity. It required dichlorination to make
ring-substtuted 1,4-phenylenediamine carcinogenic whereas only one chlorine atom was needed to make
1,2- and 1,3-phenylenediamine carcinogenic. While the available data suggest that as a class, 4-substituted
1,3-phenylenediamines are carcinogenic more often than ring-substituted 1,4-phenylenediamines, the type
of added substituent and its position on the benzene ring also are important in exerting carcinogenic
activity.
Introduction
Phenylenediamines comprise one ofseveral classes of
chemicals which are thought to contribute to the
increase of cancer risk observed among workers in the
dye manufacturing industry (1). The National Institute
for Occupational Safety and Health has estimated that
more than 64,000 people are potentially exposed in the
workplace to a group of seven phenylenediamines, the
production ofwhich is over 50 million pounds. Exposure
of the general public is estimated at more than 15
million individuals, since phenylenediamines are used in
dyes, either directly as color-yielding compounds which
include hair and fabric dyes or as intermediates and
photographic development fluids (1).
Phenylenediamines were defined by the Interagency
Testing Committee (ITC) as "all nitrogen-unsubstituted
phenylenediamines with zero to two substituents on the
ringselected from the same ordifferent members ofthe
group of halo, nitro, hydroxy, hydroxy-lower alkoxy,
lower alkyl, and lower alkoxy" (2). For this purpose, the
term "lower" is defined as a group between one and four
carbons. The ITC listed 50 phenylenediamines as occur-
ring in the Toxic Substances Control Act (TSCA) public
inventory (2).
Long-term testing for carcinogenicity of all pheny-
lenediamines and related compounds (i.e., those com-
pounds in which -NH2 is replaced by -NO2) would
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require a significant economic burden on industry. It
would be useful, therefore, to be able to determine,
from structural characteristics, which chemicals are
most likely to be carcinogenic. It was the aim of this
investigation to examine those published carcinogenic-
ity studies for which there is adequate information for
analysis and to attempt toidentify correlations between
chemical structure ofphenylenediamines and their car-
cinogenic activity.
Materials and Methods
Carcinogenicity Studies
Carcinogenicity studies with phenylenediamines and
related compounds were conducted for the National
Cancer Institute (NCI) in both sexes of Fischer 344
(3-21) or Osborne-Mendel rats (22) and B6C3Fl mice
(3-22), and generally followed the procedures outlined
in the literature (23). Carcinogenicity studies also were
conducted by Weisburger et al. (24) in male Charles
River CD rats and in random-bred albino CD-1 mice of
both sexes, derived from HaM/ICR. The chemicals
were administered in feed. Prechronic studies were
conducted to determine the maximum tolerated dose
(MTD) to be used for each sex of each species in the
chronic study. The MTD was defined by the NCI as the
highest dosethat causes anoticeable weightloss, but no
more than a 10% decrement in weight gain when
compared to appropriate controls, and that does not
produce any clinical signs of toxicity or pathologicMILMAN AND PETERSON
lesions (other than those related to neoplastic response)
that would be predicted to shorten the animal's lifespan
(23). With the exception of 2-chloro-1,4-phenylene-
diamine sulfate, N2-phenyl-1,4-phenylenediamine, and
clonitralid, all chemicals were 99% pure (3-22,24).
Analysis of Methodologies
The methods used for the conduct of the bioassays
were analyzed according to the following criteria in
order to ensure that meaningful conclusions could be
made from the results obtained.
ChemicalPurity. A plus (+) was designated when
analytical tests indicated a chemical of high (99%)
purity. Aminus (-) indicated the presence ofimpurities
(Table 1).
Number of Animals. A plus (+) designated that
there were 49 to 50 animals in chemical-treated and
control groups. A minus (-) indicated that only 20 to 25
control animals and 49 to 50 chemical-treated animals
were used, except in the studies by Weisburger et al.
(24), in which only 25 chemical-treated animals per
group were used (Table 1).
Dose Schedule. A plus (+) indicated no change in
dose scheduling throughout the bioassay. A minus (-)
indicated that some modifications in the dose schedule
occurred during the study (Table 1).
Length ofDosing. The length of dosing was noted
in weeks since it affects the total dose administered
(Table 1).
Weight. A plus (+) designated a decrease in weight
gain relative to control which is not greater than 10% at
the high dose. Aminus (-)indicated agreaterthan 10%
weight decrement relative to control at the high dose.
"NC" indicated no noticeable change in weight gain
relative to control (Table 1).
Survival. A plus (+) designated that sufficient
numbers of animals in all groups were at risk for the
development of late-appearing tumors. A minus (-)
designated poorsurvival, generally lessthan20% at 103
weeks (Table 1).
Amount ofDosing. The concentration oftest mate-
rial in the feed was noted in ppm/day since it provides a
comparison of amounts of different test substances
presented to test animals (Table 1).
Results
Analysis of Test Protocols
Before attempting to correlate carcinogenic activity
of phenylenediamines and related compounds and
changes in chemical structure, it was important to
examine firstthe methods used inthe bioassays in order
to ensure that the conclusions were based on adequate
test procedures. These findings can be seen in Table 1.
With the exception of2-chloro-1,4-phenylenediamine
sulfate (X) N2-phenyl-1,4-phenylenediamine (XV) and
clonitralid (XXIII), allchemicals were99%pure. Chemi-
cal analysis was not performed on 4-ethoxy-N1-acetyl-
1,3-phenylenediamine (XIV).
With the exception of mice given N2-phenyl-1,4,-
phenylenediamine for only 51 weeks because of sudden
markedlyreduced survival, alltest animals were fed the
appropriate diet containing the chemical for 78 to 103
weeks.
Only 20 to 25 control or chemical-treated rats and
mice were used in some experiments. However, statisti-
cal analyses ofresults from all studies exceptthose with
1,2-phenylenediamine dihydrochloride (I), 1,3-pheny-
lenediamine dihydrochloride (IV) and 1-chloro-2,4-
dinitro-benzene (XIX) compared findings in chemical-
treated groups with concurrent and with historical
controls.
While some dose changes occurred during several
chronic studies (Table 1), survival was adequate at
terminal sacrifice in all groups except in rats receiving
the high dose of 4-methyl-1,3-phenylenediamine (VI),
male rats receiving the high dose of2-methoxy-5-nitro-
aniline (XXI), and male mice receiving the high dose of
clonitralid.
A greaterthan 10% weight gain depressionrelative to
control was seen in some high dose groups in the
various bioassays (Table 1) indicating that the maximal
tolerated dose (MTD) may have been exceeded in these
groups. This finding, however, was not sufficient to
negatethe studies since, withthe exceptionof2-methyl-
5-nitroaniline(XVI)and3-nitro-4-ethoxy-N-acetylaniline
(XXII), all carcinogenic chemicals in which the high
dose caused a greater than 10% depression of mean
body weight gain relative to control were also carcino-
genic in at least one site ofone sex ofone species at the
lower dose which approximated the MTD (3-22). In the
experiment with 3-nitro-4-hydroxyaniline (XX), mice
had less than 10% weight gain depression relative to
control, indicating that the MTD may not have been
obtained.
It can be concluded, therefore, that the studies were
conducted under conditions in which the MTD was
obtained at the high dose or if exceeded, was achieved
at the lower dose. Also, good survival was generally
maintained in all groups. The period of compound
administration (78-103 weeks), although less in some
studies than previously recommended (23), neverthe-
less was adequate. Mice treated with N2-phenyl-
1,4-phenylenediamine for 51 weeks may have been able
to tolerate a longer dosing schedule at lower doses.
Carcinogenicity of Phenylenediamines and
Related Compounds
A summary of the carcinogenicity of phenylene-
diamines and related compounds (1-22,24) is outlined in
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Table 2. Ofthe 23 compounds tested, 11 werejudged not
to be carcinogenic inrats ormice. Ofthe 12 carcinogenic
chemicals, ninewerecarcinogenicfortheratand/ormouse
liver, two[4-chloro-1,2-phenylenediamine (II)and3-nitro-
4-hydroxyaniline (XX)] for the bladder ofrats, and two
[4-methoxy-1,3-phenylenediamine sulfate (VIII) and
4-ethoxy-N2-acetyl-1,3-phenylenediamine (XIV)] were
carcinogenic for rat or mouse thyroid. Other sites
affected by some of these agents were rat adrenals [by
4-chloro-1,3-phenylenediamine(V)], ratzymbalgland[by
4-methoxy-1,3-phenylenediamine sulfate (VIII)], female
rat clitoral gland (by 2-methoxy-5-nitroaniline (XXI)],
and rat skin (by 4-methyl-1,3-phenylenediamine and
2-methoxy-5-nitroaniline).
Of the nine chemicals that affected the liver of the
rodent (Table 2), eight were carcinogenic for mouse
liver, whereas only two significantly increased the in-
cidence of liver tumors in the male rat [1,2-phenylene-
diamine dihydrochloride (I) and4-methyl-1, 3-phenylene-
diamine (VI)]. 4-Methyl-1,3-phenylenediamine was also
carcinogenic for the skin ofboth sexes ofthe rat and for
the mammary gland of female Fischer 344 rats. Of the
mousehepatocarcinogens, only4-methoxy-1,3-phenylene-
diamine was also carcinogenic for other sites (i.e.,
hematopoietic system). While the high incidence ofliver
tumors (22%) in untreated male B6C3Fl mice might
suggest that this site should not be considered in the
evaluation of the carcinogenicity of these chemicals, it
should be noted that, with the exception of 3-nitro-
4-ethoxy-N-acetylaniline, allchemicalswhichwerecarci-
nogenic forthe liver ofmale mice were also carcinogenic
for the liver offemale B6C3Fl mice where the historical
control incidence ofthese neoplasms is only4.0%. These
results indicate amajor difference in the tissue sensitiv-
ityofmiceandratstothisgroupofchemicalcarcinogens.
In general, ring-substituted 1,4-phenylenediamines
and related compounds were not carcinogenic (4 of 6 of
the 1,4-phenylenediamines andrelated compounds were
not carcinogenic), ring-substituted 1,3-phenylene-
diamines and related compounds were carcinogenic (8 of
12 were carcinogenic), and not enough information was
available to conclude on the carcinogenic potential of
ring-substituted 1,2-phenylenediamines (1 of 2 were
carcinogenic).
Discussion
False Positives and False Negatives
Before making structure-activity correlations, the
possibility offalse positives and false negatives must be
considered. False positives in carcinogenicity studies
may be caused by the use of impure chemicals, the
placement of several chemicals in the room, the pres-
ence of abnormally low tumor rates in control animals,
etc., as well as random variation in results. As can be
seen from Table 1, several test criteria were not met by
anumber ofthe agents tested so that the possibility ofa
false positive in any test does exist.
The possibility offalse negatives is likelyifeffects are
small enough to escape detection in 50 animals, if the
MTD was not reached in the studies, if impure chemi-
cals were used, ifnonsusceptible species orstrains were
employed, the use of low numbers of animals, poor
survival, etc. With some chemicals, several tissue sites
did show a positive dose-response trend, suggesting
that ifthe doses were slightly higherthen the chemicals
might have been found to be carcinogenic at those sites.
Forexample, 2-chloro-1,4-phenylenediamine sulfatewas
concluded not to be carcinogenic. However, there was a
significant (p < 0.038) positive association between
dosage and the combined incidence of hepatocellular
carcinoma orhepatocellular adenomain male mice. This
findingsuggeststhat2-chloro-1,4-phenylenediamine sul-
fate may be found to be a carcinogen if retested under
more vigorous conditions.
Similar findings were seen with 2-carboxyl-5-nitro-
aniline (XVII) [positive trend (p < 0.035) in circulatory
system neoplasms in the male mouse], and with
clonitralid [positive trend in thyroid (p < 0.040) and
uterus (p < 0.036) neoplasms in female rats].
Other limitations of this evaluation which should be
noted include (1) limited data set; (2) choice of species;
(3) choice of doses; (4) variations in the incidence of
tumorsincontrolgroups; (5)biologicalvariationsinclud-
ing interspecies differences in pharmacokinetics; (6)
effect of housing (i.e., cage rotation, etc.) on results;
and(7)appropriateness ofstatisticalmethodsemployed.
Spontaneous Tumor Incidence
The abilityto detect chemicals which are carcinogenic
for specific sites of the rodent is directly dependent on
the normal, background incidence of tumors at those
sites in unexposed animals. For example, the high
incidence (22%) of hepatocellular neoplasms in un-
treated male B6C3Fl mice substantially reduces the
sensitivity of the assay method for detecting hepato-
carcinogens in this species. Likewise, comparingresults
from carcinogenicity studies conducted in different
strains of rats having differing spontaneous tumor
incidences may be difficult.
Most ofthe studiesreported herein were conducted in
both sexes of B6C3Fl mice and Fischer 344 rats.
Osborne-Mendel rats were used only in the study of
clonitralid (XXIII) and that chemical was not found to
be carcinogenic.
The spontaneous incidence ofneoplasms in untreated
Fischer344 rats isnearly comparable tothatofOsborne-
Mendel rats, with a few exceptions (25). For example,
the incidence of mammary gland tumors in untreated
female Osborne-Mendel rats is nearly 37%, whereas in
female Fischer 344 rats it is only 18%. Also, kidney
tumors appear in greater numbers in unexposed
Osborne-Mendel rats of both sexes (approximately
267MILMAN AND PETERSON
C.) 4. 0 4.)
0 ) 01 0
Ca.e Ca Ca*b
_d Cd cd
-S a.) S~ Ca -$ Cq a) c L
a) 4-JC 4.
Ca~ ~ ~ Ca _
z _~~~~~~~
a)- C a
o ~"0 0 0 c
0 4 0_0CZ *-- N
4.)
Q
CQ-~~~~~~~~P, E 9t-4 _ ) c cZ o
CIa) a )-d .ci = c
-a)
OD C
Qaci)cs
. (p-z c4 -c
0
z z 0
a1) a) aL)
0 0 0 z z z
a1)
1-o
Ce
C.)
._
L
0 0
z z
C)
:s
0
a) -4 C1)
Q:
a)
0 z
a)
0 z
Ca
z z a
a)ca"
-
a
C6"0 a
ceCa o
.-5 004
,a)
4. )
_ )
Ce Co
Ca
00 c: a}
,0 3
- .I _
0 a) - . - _
Z e H
O) 0
~CaZ -a
42') Ca C
0 o -
_ H
0 o
01 Cd Ca
E.0ClE
a
'a C) C a :
o Ca
0 E G
a)
0 z
a)
0 C.).
a , a)
- 4D r 41
) a a
~?C t
P4 VD) I1 W '
268
"0
Ca
Ca.
bla
0
4.
o
0
U2
Q_
._
P-b .a
a)
Z
rA
rA~
a._
w
a)
0
F.)
I-
w
0
CI,
a)
a1)
Ce
E a
.'XQ
0
_ Ci E
o) 0"
O
I 40s
z 6E = S
In I--,
la
9
0
0 0CARCINOGENICITY OF PHENYLENEDIAMINES
Ca
0
a1)
0la os.e C
.Ca 0 cd
a) a) ce
0 0~~~~~~~ a z =z
;: o C.)
Z z 1-
co
0
a)
-
a) -
,; .. R
ZgJ
4
W t
- W- =
C
a
J--C
aL) a) I- -
r- r. V- _ = 0 0
0 0 ._ Z 00 0 0Z
z z 1. z zz z
0
40 0 0
co
aCIS w
;C WC C)
-z _
CO
W W co) W
$- Eo Co b
;e co W-ooWW
a)
0 z
W-1 e-
o g
W -d
Ca
C)
000
z ; Z ZZ Z
.-4
4) (a) Qa) a) a) Ca a oa a = a .Ca4-. o=
0 0 0 0 0 0 0
z z z z z zz
0 0 0
z z z
Can
p. 4 oV
a) a3)
0 0
z z
I--,
._ E
t 0E
Cs3.a 0
o o o o o *'~o9 c ZZ)
z z z zz ~
a1)
0
z
~~~~~~v-4
w a) Q~-a
tc= } X
Y~a"C X
Cl)~~~~~~~~~~~~a
C)~~~~~~~~C
269
a) a) a)
0 0 0 z z z
a) a2)
0 0 z z
C) C-4
coa
om
a)=C.
0~0
CQ~MILMAN AND PETERSON
=_ C)
0
I,-
S._
a)-4
a) Z)
CU 0
0
_~
O .
zz W'
o oz o o
ce cd av Ce c CQ
C)CU; C)U6gC.)
X-
V
c
3 ] = W
M_ ce X e
e~~~~~~~~~~~v
4J c co 0 ~ CU
0~~~~~~~
,6
270
a)
0 z
ri2
"0
CU
.bel
0
._
a2
CU
._U
0.
.C
oo
*0
U,
a)
0 z
a3)
0 z
a1)
CU
0 z
a)
E
a
U,
pq
4. CU
.w.0
~ o0
C) r12 CU"
~ b
P4 0 U
&J " 3
aa)
m cn
0
C4.
co w9
:,V C L)
Ca
V)
0 "
o S B *E - 4
Zz° E s
4)
0 z
a)
0 z
a)
CU
0 z
l0
9
0
04
0 u
xO Q
I
~a)
Z %
CO
S
*E l
.R
la)
C _ =laU'CARCINOGENICITY OF PHENYLENEDIAMINES
3.5%) compared to Fischer 344 rats (0.4%) as are
thyroid tumors in female Osborne-Mendel rats (11%
versus 7%, respectively). Thmors of the uterus and
pituitary gland, however, are significantly reduced in
untreated female Osborne-Mendel rats compared to
female Fischer 344 rats (4% versus 16% and 21% versus
30%, respectively).
Differences in spontaneous tumor incidence can also
be seen between sexes of the same strain and species.
For example, whereas liver and lung neoplasms are
more abundant in untreated male B6C3F1 mice than in
the corresponding females, the incidence of pituitary
gland tumors and leukemia/lymphoma is greater in
female B6C3Fl mice than in the males (26). Similarly,
the incidence of mammary gland and pituitary gland
tumors is increased in female Fischer 344 or Osborne-
Mendel rats over the corresponding males, whereas
adrenal gland tumors appear at two to three times
greater frequency in untreated males than in female
rats (25).
Structure-Activity Relationships
1,2-Phenylenediamines. Onlythree 1,2-phenylene-
diamines were examined for carcinogenicity in this
review, and these gave conflicting findings so that no
definitive conclusion could be made on the carcinogenic
potential of this class of compounds. Compounding
further the interpretation ofthe results from this class
of compounds is the fact that 1,2-phenylenediamine
dihydrochloride was tested in male Charles River CD
rats and both sexes of random-bred albino CD-l mice
derived from HaM/ICR whereas 4-chloro-1,2-phenyl-
enediamineand4-nitro-1,2-phenylenediamine (III)were
tested in Fischer 344 rats and B6C3F1 mice of both
sexes.
Both 1,2-phenylenediamine dihydrochloride and 4-
chloro-1,2-phenylenediamine were carcinogenic. How-
ever, changing the 4-chloro- to a 4-nitro- group elimi-
nated all carcinogenic activity. Additional studies with
varied analogs are needed to analyze more fully the
carcinogenic potential of this group of compounds.
1,3-Phenylenediamines. While 1,3-phenylenedia-
mine dihydrochloride was not carcinogenic in rats or
mice, several of its ring-substituted analogs were. For
example, chlorination, methylation, or hydroxylation at
a positionparato an amine group produced acompound
with carcinogenic activity. In comparison, methylation
at a position ortho to the amine function, i.e., 2-methyl-
1,3-phenylenediamine dihydrochloride (VII) yielded a
compound which was completely inactive.
As the substituent at the fourth position of 1,3-
phenylenediamine was changed from -Cl to -CH3 to
-OCH3, the compound became carcinogenic for more
species, more sexes, and more target sites. However,
N-substitution (i.e., 4-ethoxy-N1-acetyl-1,3-phenylene-
diamine and 3-nitro-4-ethoxy-N-acetylaniline reduced
the carcinogenicity to only one site, of one sex, of
one species (male mouse thyroid or liver).
Oxidation ofone ofthe -NH2 groups to -NO2 function
substantially reduced the carcinogenicity of the com-
pounds that fell into this class. For example, 4-methyl-
1,3-phenylenediamine was carcinogenic for several sites
of male and female rats and male mice, while the
oxidation of the -NH2 function at position -1 to -NO2
group (i.e., 2-methyl-5-nitro-aniline) limited the carcino-
genicityofthe chemicalto the liverofboth sexes ofmice
only. In a similar manner, 4-methoxy-1,3-phenylene-
diamine sulfate was carcinogenic forseveral sites ofrats
and mice of both sexes whereas 2-methoxy-5-nitro-
aniline, the N1-oxidized analog, was carcinogenic only
for female rats and female mice.
Oxidation of the 4-methyl group of the N1-oxidized
analog of 1,3-phenylenediamine (i.e., 2-methyl-5-nitro-
aniline) to a carboxyl group (i.e., 2-carboxyl-5-nitro-
aniline) eliminated all carcinogenic activity. Oxidation of
both amine functions, i.e., 2,4-dinitrotoluene (XVIII),
also produced a compound which was completely
inactive.
It can be concluded, therefore, that while it appears
that 4-substituted 1,3-phenylenediamines tend to be
carcinogenic, the carcinogenicity of chemicals in this
small and nonrandom set is substantially reduced or
eliminated completely by oxidation ofone orboth amine
groups or by N-substitution. Oxidation of the methyl
substituent on nitroaniline to a carboxyl group pro-
duced a compound which was devoid of carcinogenic
activity.
1,4-Phenylenediamines. Onlyseven 1,4-phenylene-
diamines and related compounds were examined for
carcinogenicity in this review so that conclusions on
the carcinogenic potential of this class of compounds
must be viewed with caution. Of these agents, only
2,6-dichloro-1,4-phenylenediamine (XI) and 2-nitro-1,4-
phenylenediamine (XIII) were carcinogenic. These re-
sults suggest, therefore, that as a class, ring-substi-
tuted 1,4-phenylenediamines may be carcinogenic less
often than 4-substituted 1,3-phenylenediamines.
While the monochloro analog of 1,2- and 1,3-phenyl-
enediamine and the monomethyl analog of 1,3-phenyl-
lenediamine were carcinogenic for both species at
several sites, the monochloro and monomethyl analog of
1,4-phenylenediamine were completely inactive. It re-
quired dichlorination (2,6-dichloro-1,4-phenylene-
diamine) to make 1,4-phenylenediamine carcinogenic,
whereas only one chlorine atom was needed to make
1,2- and 1,3-phenylenediamine carcinogenic. Therefore,
while the data are limited, it appears that the position
of the chlorine atom in relation to the diamines on the
benzeneringmaybeimportantforcarcinogenic activity.
Both 1,2- and 1,3-phenylenediamines were carcinogenic
when the chlorine atom was para to an amine group.
The chlorine atom on 1,4-phenylenediamine, on the
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other hand, can only be ortho or meta to the amines.
This may explain the noncarcinogenicity ofmonochloro-
1,4-phenylenediamine.
That the relationship of the chlorine atom to the
amine groups on the benzene ring may be important for
the carcinogenicity of the benzenediamines is further
supported by the following examples. 4-Chloro-1,2-
phenylenediamine was carcinogenic for both sexes of
mice and rats producing rare bladder tumors in both
sexes of rats. On the other hand, 4-chloro-1,3-phenyl-
enediamine was carcinogenic only for male rats and
female mice and adrenal tumors rather than bladder
tumors were observed in male rats treated with this
agent. 2-Chloro-1,4-phenylenediamine was completely
inactive in either species tested.
Similar correlations were seen with methylated and
nitrated benzenediamines. For example, 4-methyl-
1,3-phenylenediamine was carcinogenic for several sites
of rats of both sexes and female mice, but 2-methyl-
1,4-phenylenediamine sulfate (XII) was inactive. Also,
2-nitro-1,4-phenylenediamine was carcinogenic for the
liver offemale mice while 4-nitro-1,2-phenylenediamine
was devoid of carcinogenic activity.
While 1,4-phenylenediamine dihydrochloride (IX) was
inactive in mice and rats, so were the monochloro and
monomethyl analogs ofthe parent compound. Addition
ofanitrogroup(2-nitro-1,4-phenylenediamine), however,
elicited a carcinogenic response in the liver of female
B6C3Fl mice.
Based on the available data, it can be concluded that
ring-substituted 1,4-phenylenediamines tend to be
noncarcinogens(fourofsixofthe 1,4-phenylenediamines
and related compounds were not carcinogenic). Also,
thereisoneexample(2,6-dichloro-1,4-phenylenediamine)
in which twice as many electron-withdrawing groups
(i.e., dichlorides) were needed on 1,4-phenylenediamine
than on 1,2- or 1,3-phenylenediamines in orderto obtain
nearly comparable carcinogenic activities.
Conclusions
Sontag (27) suggested that "phenylenediamines
appeared to be least active when the amine groups were
para to one another, and gained activity as they became
ortho to the substituted groups" Our evaluation, al-
though limited by the number ofcompounds examined,
is more extensive than Sontag's in that it includes
several compounds not in his review, and it analyzes in
detail the methods and results of the bioassays.
Moreover, our evaluation partially supports Sontag's
conclusion and indicates that 4-substituted 1,3-pheny-
lenediamines are carcinogenic more often than ring-
substituted 1,4-phenylenediamines. Therefore, in set-
ting priorities for consideration of phenylenediamines
for testing for carcinogenicity, the likelihood that ring-
substituted 1,3-phenylenediamines will be carcinogenic
in a long-term animal bioassay appears greater than
that of ring-substituted 1,4-phenylenediamines. How-
ever, the type of added substituent and its position on
the benzene ring also are important in predicting
carcinogenic potential. Since sufficient information is
not available presently to draw conclusions related to
1,2-phenylenediamines, these chemicals should be con-
sidered on a case by case basis.
A qualitative assessment ofthe potential for carcino-
genicity based on structural changes should provide the
basis ofadditional definitive quantitative structure-acti-
vity relationship studies based on relevant molecular
descriptors and reactivity indicators. Such studies,
however, were beyond the scope of this review.
This report has been reviewed in accordance with the U.S.
Environmental Protection Agency's peer and administrative review
policies and approved for publication. Approval does not signify that
the contents necessarily reflect the views and policies of the U.S.
Environmental Protection Agency, nor does mention of trade names
or commercial products constitute endorsement or recommendation
for use.
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